Rhythm Pharmaceuticals, Inc.
RYTM
$104.46
$3.073.03%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -21.13% | -44.55% | 64.99% | -3.98% | 1.10% |
| Total Depreciation and Amortization | -21.04% | -2.82% | -5.43% | -8.15% | -12.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 70.99% | 272.70% | -83.72% | 373.87% | -16.65% |
| Change in Net Operating Assets | -33.91% | 310.86% | -261.47% | 14.58% | 397.91% |
| Cash from Operations | -5.58% | 19.82% | 0.96% | 35.86% | 13.80% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -171.25% | 731.10% | -17.43% | -6.55% | 4.36% |
| Cash from Investing | -171.25% | 731.10% | -17.43% | -6.55% | 4.36% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3,243.70% | 145.58% | 428.24% | 743.23% | -88.54% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -66.97% | -173.09% | -65.83% | -47.94% | -115.02% |
| Cash from Financing | 7,496.35% | -100.61% | 665.94% | 1,481.84% | -96.59% |
| Foreign Exchange rate Adjustments | 150.41% | 7.31% | 97.18% | 608.85% | -883.12% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 26.97% | -72.70% | 360.05% | 1,022.38% | -123.42% |